The Food and Drug Administration (FDA) announced that it is
amending regulations to revise the list of drugs that have been withdrawn or
removed from the market because the drug products or their components have been
found to be unsafe or ineffective.
Drugs
appearing on this list may not be compounded under the exemptions provided by
sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (the
FD&C Act). Specifically, the rule adds 24 entries to this list of drug
products, modifies the description of one entry on this list, and revises the
list's title and introductory language. These revisions are necessary because
information has come to the Agency's attention since March 8, 1999, when FDA
published the original list as a final rule. See the full list.
Posted by Dr. Tim Sandle
